A Prospective Observational Study Cohort to Assess the Rate of Castration Resistance, Disease Progression and Overall Survival Over a 3-year Period Post-androgen Deprivation Therapy Induction in Patients With Advanced Prostate Cancer Who Have Previously Participated in the Triptocare Study (Http://Clinicaltrials.Gov/ct2/Show/Study/NCT01020448)
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling by invite only)
Male
Advanced Prostate Cancer
Male
Advanced Prostate Cancer
Trial Information
A Prospective Observational Study Cohort to Assess the Rate of Castration Resistance, Disease Progression and Overall Survival Over a 3-year Period Post-androgen Deprivation Therapy Induction in Patients With Advanced Prostate Cancer Who Have Previously Participated in the Triptocare Study (Http://Clinicaltrials.Gov/ct2/Show/Study/NCT01020448)
Inclusion Criteria:
- Have participated and received study treatment in the Triptocare study
- Be aware of the investigational nature of this observational study cohort and must
give written (personally signed and dated) informed consent
Exclusion Criteria:
- Absence of written informed consent from the patient
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Castration-resistant prostate cancer (CRPC)
Outcome Time Frame:
Over a 3-year period post-androgen deprivation therapy induction
Safety Issue:
No
Principal Investigator
Patrick Cabri, M.D.
Investigator Role:
Study Director
Investigator Affiliation:
Ipsen
Authority:
Denmark: Ethics Committee
Study ID:
8-79-52014-187
NCT ID:
NCT01383863
Start Date:
October 2011
Completion Date:
April 2014
Related Keywords:
- Advanced Prostate Cancer
- Prostatic Neoplasms
Name | Location |
|---|
